An economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from an English NHS perspective

FUNDING ACKNOWLEDGEMENTS: Type of funding sources: Other. Main funding source(s): This cost-effectiveness study was funded by Medtronic BACKGROUND: The UK National Institute of Care Excellence (NICE) recommend the use of pulmonary vein isolation (PVI) to treat paroxysmal atrial fibrillation (PAF) in...

Descripción completa

Detalles Bibliográficos
Autores principales: Andrade, J, Moss, J, Todd, D, Kuniss, M, Wazni, O, Chierchia, G B, Mealing, S, Sale, A, Ismyrloglou, E, Souter, M, Bromilow, T, Lane, E, Lewis, D, Paisey, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
9.4.4 - Catheter Ablation of Arrhythmias
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207462/
http://dx.doi.org/10.1093/europace/euad122.688

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207462/
http://dx.doi.org/10.1093/europace/euad122.688

Ejemplares similares